For example, the first CSC study showed that CD34+CD38- CSCs in AML share the same surface marker with hematopoietic stem cells (HSCs) (Issaad et al., 1993; Petzer et al., 1996; Bonnet and Dick, 1997). This evidence concerns the gene CD38 and acute myeloid leukemia.